dipeptidyl
ubiquit
express
proteas
regul
divers
number
physiolog
function
dipeptidas
exert
catalyt
effect
proteinspeptid
prolin
alanin
serin
penultim
amino
acid
residu
amino
terminu
evid
date
support
import
effect
catalyt
cleavag
incretin
peptid
perhap
repres
main
mechan
inhibit
improv
glycem
control
also
play
import
role
degrad
multipl
chemokin
stromal
cellderiv
also
known
perhap
increasingli
recogn
target
given
import
process
hematopoiesi
angiogenesi
stem
cell
home
current
review
summar
import
enzymat
process
cytokineschemokin
emphasi
result
implic
cardiovascular
physiolog
diseas
dipeptidyl
typeii
integr
transmembran
glycoprotein
recent
gain
attent
owe
role
catalyt
degrad
incretin
receptor
entri
middl
eastern
respiratori
syndrom
mer
viru
best
known
catalyt
function
wherebi
proteolyt
cleav
number
peptid
protein
substrat
exhibit
strong
prefer
peptid
prolin
serin
alanin
penultim
amino
acid
amino
terminu
nterminu
glucagon
insulotrop
peptid
gip
glucagonlik
consist
tyrala
hisala
respect
render
excel
substrat
addit
role
modul
incretin
peptid
gip
regul
immun
respons
via
cleavag
mani
cytokin
chemokin
includ
stromal
cellderiv
also
known
involv
immun
function
physiolog
function
angiogenesi
review
focu
regulatori
aspect
chemokin
potenti
implic
pathogenesi
manag
cardiovascular
diseas
dipeptidyl
also
call
cluster
adenosin
deaminasebind
protein
adabind
protein
member
peptidas
famili
consist
structur
homolog
proteolyt
enzym
includ
also
call
quiescent
cell
prolin
dipeptidas
qpp
fibroblast
activ
protein
fap
first
identifi
new
dipeptid
naphthylamidas
subsequ
found
ident
cell
activ
antigen
adabind
protein
mous
thymocyteactiv
molecul
rat
liver
membran
glycoprotein
consist
short
ntermin
intracellular
domain
residu
transmembran
domain
amino
acid
larg
ctermin
extracellular
domain
ctermin
extracellular
domain
respons
catalyt
activ
bind
number
ligand
ada
matrix
protein
catalyt
activ
depend
dimer
glycosyl
specif
residu
also
assembl
tetram
cell
surfac
may
involv
linkag
dimer
locat
surfac
two
differ
cell
enabl
function
cellcel
commun
molecul
addit
membranebound
form
also
circul
solubl
form
plasma
lack
cytoplasm
transmembran
domain
preserv
catalyt
activ
solubl
homodim
molecular
weight
rang
kda
form
higher
molecular
weight
assembl
migrat
complex
whether
cleav
membran
secret
unclear
instanc
studi
investig
viral
liver
infect
suggest
shed
membranebound
howev
also
detect
lumen
secretori
granul
pancreat
cell
exocyt
secretori
lysosom
natur
killer
cell
commonli
elev
mani
disord
solid
tumor
reactiv
airway
diseas
hepat
c
type
diabet
obes
tissu
distribut
cell
specif
express
phenotyp
mice
dipeptidyl
wide
distribut
throughout
bodi
tabl
particularli
high
express
apic
surfac
endotheli
differenti
epitheli
cell
bone
marrow
cell
brush
border
small
intestin
proxim
tubular
cell
glomerular
cell
kidney
express
high
level
well
present
endotheli
cell
fibroblast
throughout
bodi
among
hematopoiet
cell
express
highest
level
cell
lower
level
monocyt
dendrit
cell
express
increas
potenti
function
serv
adipokin
mediat
obesityinduc
metabol
syndrom
adipos
tissu
macrophag
dendrit
cell
enhanc
cell
inflamm
obesityinduc
insulin
resist
cell
promot
cell
activ
provid
costimulatori
signal
endotheli
cell
regul
endotheli
function
vascular
tone
epitheli
cell
express
epitheli
cell
kidney
lung
gi
tract
mediat
merscov
infect
lung
kidney
fibrosi
diabet
nephropathi
intestin
growth
hepatocyt
involv
lipogenesi
liver
damag
monocyt
differenti
antigenpres
cell
well
cell
activ
express
high
level
kidney
spleen
lung
pancrea
prostat
mice
lack
gene
encod
refractori
develop
obes
hyperinsulinemia
demonstr
improv
postprandi
glucos
control
mice
delet
fertil
appear
healthi
slight
decreas
bodi
weight
mice
observ
compar
wild
type
normal
fast
blood
glucos
level
show
reduc
glycem
excurs
oral
glucos
challeng
increas
intact
insulinotrop
form
circul
insulin
seen
mice
oral
glucos
stimul
pair
feed
indirect
calorimetri
studi
indic
reduc
food
intak
increas
energi
expenditur
account
resist
high
fat
dietinduc
obes
mice
ablat
delet
associ
improv
metabol
control
improv
insulin
sensit
reduc
pancreat
islet
hypertrophi
protect
streptozotocininduc
loss
cell
mass
hyperglycemia
pharmacolog
inhibit
enzymat
activ
improv
glucos
toler
wildtyp
mice
interestingli
inhibitor
also
improv
glucos
toler
mice
indic
contribut
blood
glucos
regul
control
activ
well
addit
substrat
dipeptidyl
shown
abl
cleav
number
chemokin
cytokin
includ
granulocytemacrophag
colonystimul
factor
gmcsf
granulocyt
colonystimul
factor
gcsf
erythropoietin
epo
regul
activ
normal
tcell
express
presum
secret
rant
also
known
macrophagederiv
chemokin
mdc
also
known
eotaxin
also
known
monokin
induc
mig
also
known
also
known
interferoninduc
tcell
chemoattract
itac
also
known
tabl
regul
cytokin
level
catalyt
cleavag
may
influenc
level
tissu
domain
differenti
contribut
regul
cytokin
obvious
depend
level
express
may
vari
depend
tissu
cell
predominantli
express
cytokin
interest
diseas
context
addit
circul
cell
free
may
also
contribut
catalyt
activ
truncat
rant
abolish
chemotact
activ
monocyt
cell
eotaxin
eosinophil
chemotact
protein
shown
involv
allerg
respons
truncat
eotaxin
inactiv
chemotact
activ
eosinophil
eotaxin
show
impair
bind
signal
addit
truncat
eotaxin
suppress
calcium
signal
chemotaxi
intact
eotaxin
inhibit
either
genet
delet
pharmacolog
inhibit
enhanc
eotaxininduc
mobil
eosinophil
blood
recruit
injuryinject
site
mdc
chemoattract
monocyt
dendrit
cell
nk
cell
chronic
activ
lymphocyt
mdc
display
preserv
chemotact
activ
toward
monocyt
less
potenc
toward
lymphocyt
dendrit
cell
interact
mig
itac
target
cleavag
chemokin
attenu
chemotact
activ
cleav
product
serv
endogen
antagonist
bind
dipeptidyl
also
involv
inactiv
multipl
colonystimul
factor
csf
thu
regul
hematopoiet
stem
cell
hsc
hematopoiet
progenitor
cell
hpc
function
prolif
action
gmcsf
gcsf
erythropoietin
epo
hpc
enhanc
knockout
mice
pretreat
inhibitor
catalyt
inhibit
defici
promot
engraft
hsc
hpc
bone
marrow
transplant
mice
csf
may
suppress
activ
respect
fulllength
csf
via
antagon
stromal
cellderiv
peptid
encod
chemoattract
lymphocyt
bone
marrow
stem
cell
hsc
endotheli
progenitor
cell
epc
mesenchym
stem
cell
msc
endogen
cardiac
stem
cell
csc
adiposederiv
regen
cell
sever
isoform
result
altern
splice
mrna
among
isoform
best
describ
express
mani
tissu
includ
bone
marrow
heart
liver
kidney
thymu
spleen
skelet
muscl
brain
cardiovascular
system
express
stromal
cell
endotheli
cell
cardiomyocyt
typic
inactiv
exopeptidas
matrix
metalloproteinas
mmp
unlik
cleavag
posit
mmp
cleav
posit
lead
loss
bind
activ
rel
contribut
peptidas
regul
level
unclear
alphachemokin
receptor
specif
belong
famili
gproteincoupl
receptor
express
rang
progenitor
cell
includ
hematopoiet
endotheli
csc
thu
import
cell
migrat
organ
develop
embryogenesi
mice
defici
either
display
abnorm
blymphocyt
hepat
cardiac
ventricular
septal
defect
develop
die
utero
lossoffunct
mutat
human
also
caus
impair
neutrophil
mobil
bcell
lymphopenia
addit
also
suggest
import
receptor
howev
rel
contribut
interact
fulli
elucid
involv
cardiovascular
diseas
also
yet
known
may
also
play
gener
role
regul
csf
activ
stem
cell
home
previous
believ
disrupt
interact
receptor
express
hematopoiet
progenitor
express
bone
marrow
stromal
cell
suffici
detach
anchor
progenitor
bone
marrow
nich
lead
rapid
mobil
peripher
blood
also
term
plerixafor
inhibit
migrat
vitro
block
chemokin
bind
major
receptor
amd
mobil
immatur
progenitor
cell
bone
marrow
blood
approv
clinic
mobil
lymphoma
multipl
myeloma
patient
undergo
autolog
transplant
combin
gcsf
synergist
augment
mobil
progenitor
cell
increas
vitro
migrat
gradient
facilit
repopul
transplant
nonobes
diabeticsever
combin
immunodefici
mice
amd
recent
shown
directli
induc
releas
human
bone
marrow
osteoblast
endotheli
cell
releas
cell
circul
repres
pivot
mechan
essenti
steadyst
egress
rapid
mobil
hpc
axi
shown
critic
tissu
repair
multipl
organ
system
includ
eye
heart
kidney
liver
brain
skin
specif
heart
axi
shown
essenti
cardiogenesi
well
known
key
regul
stem
cell
migrat
site
tissu
injuri
first
identifi
askari
et
al
key
regul
stem
cell
migrat
ischem
cardiac
tissu
stem
cell
express
receptor
high
level
myocardi
infarct
level
elev
h
infarct
return
baselin
day
reduc
low
level
thereaft
overexpress
ischem
cardiomyopathi
either
engin
cellbas
plasmidbas
approach
improv
cardiac
function
rat
via
enhanc
stem
cell
home
promot
revascular
infarct
area
therefor
abil
express
local
believ
enhanc
vasculogen
potenti
adult
cardiac
progenitor
cell
howev
enhanc
endogen
stem
cellbas
repair
appear
blunt
due
short
halflif
time
acut
myocardi
infarct
owe
degrad
proteas
major
enzym
mediat
degrad
may
repres
potenti
target
improv
stem
cell
home
stem
cellbas
therapi
preserv
inhibit
shown
promot
stem
cell
repopul
home
ischem
tissu
inhibitor
diprotin
valpyr
enhanc
chemotaxi
hsc
hpc
greatli
increas
home
engraft
capac
hsc
pretreat
hsc
inhibitor
diprotin
enhanc
repopul
abil
lethal
irradi
mice
enhanc
engraft
human
cord
blood
cell
inhibit
also
observ
xenogen
mous
recipi
nodscid
nodscidbeta
null
pretreat
either
donor
cell
vitro
recipi
vivo
abl
enhanc
engraft
stem
cell
lung
transplant
model
system
inhibit
vildagliptin
increas
level
plasma
spleen
lung
accompani
signific
increas
stem
cell
lung
graft
inhibitortr
mice
also
show
less
alveolar
edema
compar
untreat
recipi
liebler
show
inhibit
enhanc
axi
increas
retent
human
bone
marrowderiv
cell
injur
lung
immun
defici
mice
addit
inhibit
also
enhanc
bone
marrow
engraft
preserv
gcsf
gmcsf
gcsf
gmcsf
substrat
inhibit
promot
bone
marrow
engraft
also
csfdepend
mechan
gcsf
gmcsf
turn
may
also
increas
express
cell
result
decreas
respons
angiogenesi
vasculogenesi
immens
complex
process
requir
coordin
action
multitud
cell
transcript
factor
cytokin
work
concert
precis
choreograph
manner
wide
believ
process
recapitul
adult
particip
progenitor
cell
popul
epc
perhap
best
describ
wide
believ
import
build
block
assembl
function
vasculatur
adult
origin
epc
still
controversi
clear
cell
capac
differenti
matur
endotheli
cell
implant
ex
vivoexpand
epc
shown
improv
neovascular
injur
tissu
anim
model
play
pivot
role
traffick
home
epc
ischem
tissu
level
increas
plasma
ischem
tissu
shortli
ischem
injuri
respons
hypoxia
upregul
upregul
bind
promot
initi
transcript
ex
vivo
prime
enhanc
proangiogen
potenti
epc
evidenc
improv
blood
flow
recoveri
transplant
nude
mous
model
hindlimb
ischemia
diseas
state
diabet
associ
upregul
may
repres
prototyp
condit
associ
defect
home
integr
epc
owe
rapid
degrad
kanki
et
al
report
could
cleav
plasma
ischem
heart
tissu
shih
demonstr
improv
epc
number
endotheli
nitric
oxid
synthetas
eno
express
inhibit
transient
engin
cellbas
plasmidbas
overexpress
ischem
cardiomyopathi
shown
improv
cardiac
function
anim
model
studi
compar
effect
overexpress
msc
alon
mesenchym
stem
cell
engin
overexpress
mscsdf
cardiac
function
lewi
rat
acut
myocardi
infarct
tail
vein
infus
msc
day
acut
myocardi
infarct
led
improv
cardiac
function
echocardiographi
respect
compar
salin
control
benefici
effect
mscsdf
transplant
suggest
mediat
preserv
rather
regener
cardiac
myocyt
within
infarct
area
cardiac
progenitor
cell
express
cardiac
myocyt
requir
local
trophic
effect
msc
mechan
action
overexpress
myocardi
infarct
heart
failur
like
multifactori
includ
system
direct
trophic
effect
import
effect
effect
recruit
csc
infarct
infarct
border
zone
deliveri
msc
engin
overexpress
time
acut
myocardi
infarct
shown
lead
improv
cardiac
function
myocardi
repair
initi
endogen
stem
cell
appear
blunt
natur
shortterm
express
time
acut
myocardi
infarct
light
effect
regul
inhibit
suggest
potenti
benefit
cardiovascular
diseas
myocardi
infarct
peripher
artreri
diseas
combin
gcsf
inhibit
augment
myocardi
regener
improv
cardiac
function
myocardi
infarct
mice
combin
overexpress
diprotin
treatment
shown
improv
myocardi
function
repair
infarct
myocardium
bioengin
proteaseresist
form
shown
greater
potenc
promot
blood
flow
recoveri
hindlimb
ischemia
improv
cardiac
function
well
capillari
densiti
infarct
heart
dual
inject
gcsf
sitagliptin
result
mobil
progenitor
cell
reliev
symptom
endstag
heart
failur
boy
proteaseresist
form
display
enhanc
potenc
improv
blood
flow
experiment
peripher
arteri
diseas
myocardi
infarct
shown
parathyroid
hormon
treatment
myocardi
infarct
improv
chemotaxi
cardiovascular
diseas
frontier
immunolog
wwwfrontiersinorg
surviv
myocardi
function
potenti
involv
enhanc
home
bone
marrowderiv
stem
cell
huber
et
al
demonstr
parathyroid
hormon
serv
inhibitor
increas
cardiac
level
turn
enhanc
bone
marrowderiv
stem
cell
home
ischem
heart
attenu
ischem
cardiomyopathi
infarct
haverslag
show
preserv
inhibitor
increas
monocyt
extravas
thu
acceler
perfus
recoveri
without
detriment
side
effect
plaqu
stabil
atherosclerosispron
apo
mice
figur
depict
modul
level
myocardium
inhibit
enhanc
myocardi
angiogenesi
level
porcin
model
hf
deliveri
plasmid
endomyocardi
inject
cathet
demonstr
safeti
dose
mg
improv
cardiac
function
vasculogenesi
day
postinject
dose
mg
phase
dose
escal
studi
month
followup
ischem
cardiomyopathi
subject
new
york
heart
associ
class
iii
heart
failur
eject
fraction
stabl
medic
therapi
enrol
receiv
mg
plasmid
via
endomyocardi
inject
primari
end
point
safeti
efficaci
month
respect
primari
safeti
end
point
major
advers
cardiac
event
efficaci
end
point
chang
qualiti
life
new
york
heart
associ
nyha
class
walk
distanc
singl
photon
emiss
comput
tomographi
ntermin
probrain
natruret
peptid
echocardiographi
month
primari
safeti
end
point
met
month
cohort
demonstr
improv
walk
distanc
qualiti
life
nyha
class
stromal
cellderiv
plasmid
treatment
patient
heart
failur
stophf
phase
ii
doubleblind
random
placebocontrol
trial
evalu
safeti
efficaci
singl
treatment
plasmid
deliv
via
endomyocardi
inject
patient
ischem
heart
failur
primari
endpoint
composit
chang
min
walk
distanc
minnesota
live
heart
failur
questionnair
baselin
month
followup
primari
endpoint
met
p
patient
treat
trend
toward
improv
left
ventricular
eject
fraction
month
placebo
vs
vs
mg
vs
vs
p
patient
first
tertil
ef
receiv
mg
demonstr
increas
ef
compar
decreas
placebo
p
month
although
reason
overal
failur
current
unclear
differenti
benefit
advanc
left
ventricl
dysfunct
rais
possibl
differenti
mechan
would
oper
advanc
patient
includ
possibl
overexpress
cardiac
myocyt
infarct
border
lead
neg
inotrop
state
transient
overexpress
ischem
cardiomyopathi
shown
lead
longterm
downregul
cardiac
myocyt
express
rerecruit
contractil
function
border
zone
patient
greater
left
ventricl
dysfunct
like
greater
volum
myocardi
tissu
stress
therefor
greater
demonstr
respons
overexpress
anoth
import
reason
could
upregul
border
zone
infarct
around
ischem
area
may
result
rapid
degrad
limit
efficaci
approach
sinc
phase
phase
ii
studi
perform
absenc
inhibit
could
specul
result
may
differ
trial
perform
either
presenc
inhibitor
figur
dipeptidyl
inhibit
modul
myocardi
angiogenesi
express
increas
myocardi
infarct
suppress
enzymat
activ
pharmacolog
inhibitor
preserv
result
enhanc
home
progenitor
cell
bone
marrow
infarct
tissu
chemokin
cxc
motif
receptor
inhibitor
mi
myocardi
infarct
stromalderiv
chemotaxi
cardiovascular
diseas
frontier
immunolog
wwwfrontiersinorg
due
import
axi
stem
cell
progenitor
cell
surviv
function
understand
axi
molecul
modul
product
action
util
treatment
cardiovascular
diseas
number
clinic
approv
drug
includ
inhibitor
parathyroid
hormon
abil
enhanc
respons
may
improv
outcom
cardiovascular
diseas
sever
recent
larg
scale
clinic
trial
indic
unlik
oral
antidiabet
drug
promot
cardiovascular
diseas
inhibitor
safe
cardiovascular
standpoint
despit
lack
evid
show
benefici
effect
extent
axi
contribut
effect
requir
investig
work
support
grant
aha
midatlant
nutrit
obes
research
center
norc
pilot
feasibl
program
dr
zhong
